SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-122057
Filing Date
2023-11-29
Accepted
2023-11-29 16:31:31
Documents
12
Period of Report
2023-11-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2331790d1_8k.htm   iXBRL 8-K 24667
  Complete submission text file 0001104659-23-122057.txt   195402

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clrb-20231121.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20231121_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20231121_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2331790d1_8k_htm.xml XML 3216
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 231452672
SIC: 2834 Pharmaceutical Preparations